Delivery Order SPE2DB24D2205-SPE2DB25FEHNS
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,409.96 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price, non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,353.59 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a $24,926.44 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This non-set-aside, firm fixed-price contract is classified as a delivery order with an ultimate completion date of July 16, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $8,318.78 delivery order to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a routine pharmaceutical supply delivery. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,757.37 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Monovisc 88 mg/4 mL syringes. The order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by July 30, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made on a firm fixed-price basis with no set-aside designation, indicating it was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $4.17K. This is a firm fixed-price, competitively awarded contract with no set-aside designation, and is scheduled for completion by May 28, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $38,034.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Monovisc 88 mg/4 ml syringes. The contract, which is not set-aside and was competitively awarded, requires completion by June 18, 2025, with performance to be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,453.60 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This delivery order, issued on a firm fixed-price basis with no set-aside designation, represents a competitive award for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $23,371.64. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $7,046.76 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger indefinite delivery...